Client News
Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda® biosimilar candidate FYB206 for the MENA Region
4th December 2025
DoctorBox Adds Mainz Biomed’s ColoAlert® to Its Portfolio DNA-based Colorectal Cancer Screening as a Home Test
2nd December 2025
Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions
2nd December 2025
Tacalyx Appoints Jean Engela as Chief Executive Officer to Spearhead Next Phase of Growth
2nd December 2025
CARBIOS and Wankai New Materials sign the definitive agreement establishing a strategic partnership to the large-scale deployment of CARBIOS’s PET biorecycling technology in Asia
2nd December 2025
AFYREN raises €23 million through share capital increase to finance optimization and expansion of unique biorefinery AFYREN NEOXY
26th November 2025
CARBIOS signs two new multi-year commercial agreements for recycled PET with major players in the beverage industry
24th November 2025
Heidelberg Pharma Announces Changes to the Executive Management Board – Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer
24th November 2025
MIG Capital, via its MIG Fonds, Leads €16 Million Seed Financing for AI Hardware Startup NcodiN
20th November 2025
Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America
18th November 2025
There is no more content to load